Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond E Meyn

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Molecular Cancer Therapeutics|September 18, 2015
Acute Tumor Lactate Perturbations as a Biomarker of Genotoxic Stress: Development of a Biochemical ModelVlad C Sandulache, Yunyun Chen, Heath D Skinner, et al.
American Journal of Clinical Oncology|October 7, 2003
Report from the Radiation Oncology Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2003Paul Okunieff, Raymond E Meyn, Beverly A Teicher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Predicting radiosensitivity using DNA end-binding complex analysisSheikh M Ismail, Monica Puppi, Sheela Prithivirajsingh, et al.
Current Gene Therapy|February 16, 2006
MDA-7/IL-24-based cancer gene therapy: translation from the laboratory to the clinicSatoshi Inoue, Manish Shanker, Ryo Miyahara, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2003
MDA-7 negatively regulates the beta-catenin and PI3K signaling pathways in breast and lung tumor cellsAbner M Mhashilkar, Alexis L Stewart, Kerry Sieger, et al.
Oncotarget|February 11, 2017
Metabolic interrogation as a tool to optimize chemotherapeutic regimensVlad C Sandulache, Yunyun Chen, Lei Feng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 6, 2014
Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancerMaria Angelica Cortez, David Valdecanas, Xiaochun Zhang, et al.
International Journal of Radiation Biology|February 20, 2020
Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpointsJessica M Molkentine, David P Molkentine, Kathleen A Bridges, et al.
Molecular Cancer Therapeutics|December 16, 2014
Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescenceAbdullah A Osman, Marcus M Monroe, Marcus V Ortega Alves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2017
Integrative Analysis Identifies a Novel AXL-PI3 Kinase-PD-L1 Signaling Axis Associated with Radiation Resistance in Head and Neck CancerHeath D Skinner, Uma Giri, Liang P Yang, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Molecular Cancer Therapeutics|September 18, 2015
Acute Tumor Lactate Perturbations as a Biomarker of Genotoxic Stress: Development of a Biochemical ModelVlad C Sandulache, Yunyun Chen, Heath D Skinner, et al.
American Journal of Clinical Oncology|October 7, 2003
Report from the Radiation Oncology Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2003Paul Okunieff, Raymond E Meyn, Beverly A Teicher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Predicting radiosensitivity using DNA end-binding complex analysisSheikh M Ismail, Monica Puppi, Sheela Prithivirajsingh, et al.
Current Gene Therapy|February 16, 2006
MDA-7/IL-24-based cancer gene therapy: translation from the laboratory to the clinicSatoshi Inoue, Manish Shanker, Ryo Miyahara, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2003
MDA-7 negatively regulates the beta-catenin and PI3K signaling pathways in breast and lung tumor cellsAbner M Mhashilkar, Alexis L Stewart, Kerry Sieger, et al.
Oncotarget|February 11, 2017
Metabolic interrogation as a tool to optimize chemotherapeutic regimensVlad C Sandulache, Yunyun Chen, Lei Feng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 6, 2014
Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancerMaria Angelica Cortez, David Valdecanas, Xiaochun Zhang, et al.
International Journal of Radiation Biology|February 20, 2020
Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpointsJessica M Molkentine, David P Molkentine, Kathleen A Bridges, et al.
Molecular Cancer Therapeutics|December 16, 2014
Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescenceAbdullah A Osman, Marcus M Monroe, Marcus V Ortega Alves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2017
Integrative Analysis Identifies a Novel AXL-PI3 Kinase-PD-L1 Signaling Axis Associated with Radiation Resistance in Head and Neck CancerHeath D Skinner, Uma Giri, Liang P Yang, et al.
Pageof 5